Status:
COMPLETED
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Arteriosclerosis
Eligibility:
FEMALE
45-75 years
Phase:
PHASE3
Brief Summary
To determine if estrogen replacement therapy, with or without low dose progesterone, slows progression or induces regression of coronary atherosclerosis in postmenopausal women.
Detailed Description
BACKGROUND: Cardiovascular disease is the number one cause of death in postmenopausal women. Postmenopausal estrogen replacement is associated with a lower incidence of cardiovascular disease in wome...
Eligibility Criteria
Postmenopausal women with established coronary atherosclerosis.
Key Trial Info
Start Date :
August 1 1994
Trial Type :
INTERVENTIONAL
End Date :
July 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000549
Start Date
August 1 1994
End Date
July 1 2000
Last Update
March 16 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.